Corynebacterium periprosthetic joint infection: a systematic review of 52 cases at 2.5 years follow-up

Arch Orthop Trauma Surg. 2023 Sep;143(9):5527-5538. doi: 10.1007/s00402-023-04844-8. Epub 2023 Mar 30.

Abstract

Introduction: While large progress has been achieved in identifying and treating the most common pathogens involved in periprosthetic joint infections (PJI), there remains limited knowledge on atypical pathogens such as Corynebacterium. For that reason, we analyzed infection and diagnostical characteristics, as well as treatment outcome in Corynebacterium PJI.

Methods: A systematic review was performed based on a structured PubMed and Cochrane Library analysis using the PRISMA algorithm. The search was performed by 2 independent reviewers, and articles from 1960 to 2022 considered eligible for inclusion. Out of 370 search results, 12 studies were included for study synthesis.

Results: In total, 52 cases of Corynebacterium PJI were identified (31 knees, 16 hips, 4 elbows, 1 shoulder). Mean age was 65 years, with 53% females, and a mean Charlson Comorbidity Index of 3.9. The most common species was Corynebacterium striatum in 37 cases (71%). Most patients were treated with two-stage exchange (40%), isolated irrigation and debridement (21%), and resection arthroplasty (19%). Mean duration of antibiotic treatment was 8.5 weeks. At a mean follow-up of 2.5 years, there were 18 reinfections (33%), and 39% were for Corynebacterium. Initial infection by Corynebacterium striatum species was predictive of reoperation (p = 0.035) and reinfection (p = 0.07).

Conclusion: Corynebacterium PJI affects multimorbid and elderly patients, with one in three developing a reinfection at short term. Importantly, the relative majority of reinfections was for persistent Corynebacterium PJI.

Keywords: Atypical pathogens; Difficult to treat pathogens; Elbow infection; Gram-positive PJI; Hip infection; Knee infection; Shoulder infection.

Publication types

  • Systematic Review
  • Review

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Corynebacterium
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Prosthesis-Related Infections* / surgery
  • Reinfection / drug therapy
  • Reoperation / methods
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents

Supplementary concepts

  • Corynebacterium striatum